ENTPD1 and neoplasm: Furthermore, the authors demonstrated, through co-culture experiments, that both CD39 and CD73 exhibit enzymatic activity on Sézary cells, contributing to the generation of extracellular adenosine, driving the suppression of anti-tumor immune responses [47].